The Genome Editing Market is expected to grow significantly due to advancements in gene therapy technologies and the increasing demand for genetically modified organisms (GMOs) in agriculture and ...

Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive ...

该工作系统研究了AsCas12f1及其改进型突变体对靶DNA切割过程的动力学分子机制。研究发现，AsCas12f1解旋原间隔区内DNA后，在非靶链DNA上产生缺口（nick）并进行双向外切模式的核酸降解；随后，AsCas12f1把DNA解旋范围扩展到 ...

施普林格•自然旗下汇聚了一系列深得信赖的品牌，包括施普林格、Nature Portfolio、BMC、帕尔格雷夫•麦克米伦和《科学美国人》。AdisInsight是Springer旗下面向药物研发、疾病治疗和决策的数据库。1. Editas Medicine与Genevant Sciences合作开发新型mRNA-LNP基因编辑疗法Editas Medicine与Genevant Sciences ...

第二十六届中国国际高新技术成果交易会（高交会）11月14日在深圳国际会展中心（宝安）盛大开幕！展会现场共有来自全球100多个国家和地区的5000余家高新技术企业参展，其中世界500强企业及央企180余家，上市公司1000余家，瞪羚企业、独角兽企业20 ...

Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parco Area Delle Scienze 17/A, 43124 Parma, Italy ...

Harbinger developed a novel CRISPR/Cas12a-based method depleting unmethylated CpG sites at precise locations, in non-cancerous cfDNA. The remaining DNA is enriched for methylated, ctDNA molecules.

A pipeline for the analysis of CRISPR edited data. It allows the evaluation of the quality of gene editing experiments using targeted next generation sequencing (NGS) data (`targeted`) as well as the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The CRISPR molecular scissors have the potential to revolutionize the treatment of genetic diseases. This is because they can be used to correct specific defective sections of the genome.